Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 81283-81284 [2010-32464]

Download as PDF Federal Register / Vol. 75, No. 247 / Monday, December 27, 2010 / Notices or before January 10, 2011. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by January 11, 2011. Persons attending FDA’s advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Conference Management Staff, 301–796–5966, at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/Advisory Committees/AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: December 20, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–32367 Filed 12–23–10; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0001] Oncologic Drugs Advisory Committee; Cancellation AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The meeting of the Oncologic Drugs Advisory Committee scheduled for February 9, 2011, is cancelled. This meeting was announced in the Federal Register of December 6, 2010 (75 FR 75680). On February 9, 2011, the Oncologic Drugs Advisory Committee was scheduled to discuss biologics license application (BLA) 125377, with the proposed trade name YERVOY (ipilimumab), submitted by Bristol- erowe on DSK5CLS3C1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:15 Dec 23, 2010 Jkt 223001 Myers Squibb Co. The proposed indication (use) for this product is for the treatment of advanced melanoma in patients who have received prior therapy. This meeting has been cancelled because the issues for which FDA was seeking the scientific input of the committee have been resolved. FOR FURTHER INFORMATION CONTACT: Nicole Vesely, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, rm. 2417, Silver Spring, MD 20993–0002, 301– 796–9001, FAX: 301–847–8533, e-mail: Nicole.vesely@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. Dated: December 21, 2010. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2010–32413 Filed 12–23–10; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Child Health and Human Development Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 81283 Name of Committee: National Advisory Child Health and Human Development Council. Date: January 20, 2011. Open: 8 a.m. to 12:20 p.m. Agenda: (1) A report of the Director, NICHD; (2) Select Pay Plan Presentation; (3) NIH Peer Review Enhancement Update, (4) NIH Support for Human Embryonic Stem Cell Research Update. Place: National Institutes of Health, Building 31, 31 Center Drive, C–Wing, Conference Room 6, Bethesda, MD 20892. Closed: 12:20 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 31 Center Drive, C–Wing, Conference Room 6, Bethesda, MD 20892. Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National Institute of Child Health and Human Development, NIH, 9000 Rockville Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892. (301) 496–1848. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/nachhd.htm, where an agenda and any additional information for the meeting will be posted when available. In order to facilitate public attendance at the open session of Council, reserve seating will be made available to the first five individuals reserving seats in the main meeting room, Conference Room 6. Please contact Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301–496–0536 to make your reservation. Additional seating will be available in the meeting overflow rooms, Conference Rooms 7 and 8. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at: https:// wwwauthor.nichd.nih.gov/about/overview/ advisory/nachhd/virtual-meeting201005.cfm. The meeting is partially closed to the public. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) E:\FR\FM\27DEN1.SGM 27DEN1 81284 Federal Register / Vol. 75, No. 247 / Monday, December 27, 2010 / Notices Dated: December 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–32464 Filed 12–23–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2010–0094] National Protection and Programs Directorate; National Infrastructure Advisory Council Meeting National Protection and Programs Directorate, DHS. ACTION: Committee Management; Notice of Federal Advisory Council Meeting. AGENCY: The National Infrastructure Advisory Council (NIAC) will meet on Tuesday, January 18, 2011, at the JW Marriott Washington DC, Salon I, 1331 Pennsylvania Avenue, NW., Washington, DC 20004. DATES: The NIAC will meet Tuesday, January 18, 2011, from 1:30 p.m. to 4:30 p.m. The meeting may close early if the committee has completed its business. For additional information, please consult the NIAC Web site, https://www. dhs.gov/niac, or contact the NIAC Secretariat by phone at 703–235–2888 or by e-mail at NIAC@dhs.gov. ADDRESSES: The meeting will be held at the JW Marriott Washington DC, Salon I, 1331 Pennsylvania Avenue, NW., Washington, DC 20004. SUPPLEMENTARY INFORMATION: Notice of this meeting is given under the Federal Advisory Committee Act, 5 U.S.C. App. (Pub. L. 92–463). The NIAC shall provide the President through the Secretary of Homeland Security with advice on the security of the critical infrastructure sectors and their information systems. The NIAC will meet to address issues relevant to the protection of critical infrastructure as directed by the President. At this meeting the committee will receive work from a NIAC working group to review, deliberate on, and provide further direction to the working group. Meeting Agenda: I. Opening of Meeting II. Roll Call of Members III. Opening Remarks and Introductions IV. Approval of October 19, 2010, Minutes V. Deliberation: Information Sharing Study VI. Public Comment VII. Closing Remarks VIII. Adjournment erowe on DSK5CLS3C1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:15 Dec 23, 2010 Jkt 223001 Procedural: While this meeting is open to the public, participation in the NIAC deliberations is limited to committee members and appropriate Federal Government officials. Discussions may include committee members, appropriate Federal Government officials, and other invited persons attending the meeting to provide information that may be of interest to the Council. Immediately following the committee member deliberation and discussion period, there will be a limited time period for public comment on listed agenda items only. Relevant public comments may be submitted in writing or presented in person for the Council to consider. Off-topic questions or comments will not be permitted or discussed. In-person presentations will be limited to three minutes per speaker, with no more than 30 minutes for all speakers. Parties interested in making in-person comments must register no less than 15 minutes prior to the beginning of the meeting at the meeting location. Oral comments will be permitted based upon the order of registration; all registrants may not be able to speak if time does not permit. Written comments may be sent to Nancy Wong, Department of Homeland Security, National Protection and Programs Directorate, 245 Murray Lane, Mail Stop 0607, Washington, DC 20528– 0607. Written comments must be received by Nancy Wong no later than January 11, 2011, identified by Federal Register Docket Number DHS–2010– 0094, and may be submitted by any one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting written comments. • E-mail: NIAC@dhs.gov. Include the docket number in the subject line of the message. • Fax: 703–603–5098. • Mail: Nancy Wong, National Protection and Programs Directorate, Department of Homeland Security, 245 Murray Lane, Mail Stop 0607, Washington, DC 20528–0607. Instructions: All written submissions received must include the words ‘‘Department of Homeland Security’’ and the docket number for this action. Written comments received will be posted without alteration at https://www. regulations.gov, including any personal information provided. Docket: For access to the docket to read background documents or comments received by the NIAC, go to https://www.regulations.gov. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 Information on Services for Individuals with Disabilities: For information on facilities or services for individuals with disabilities or to request special assistance at the meeting, contact the NIAC Secretariat at 703–235–2888 as soon as possible. FOR FURTHER INFORMATION CONTACT: Nancy Wong, National Infrastructure Advisory Council Designated Federal Officer, Department of Homeland Security, telephone 703–235–2888. Signed: December 17, 2010. Nancy J. Wong, Designated Federal Officer for the NIAC. [FR Doc. 2010–32347 Filed 12–23–10; 8:45 am] BILLING CODE 9110–9P–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2009–0166] Nationwide Use of High Frequency and Ultra High Frequency Active SONAR Technology; Draft Programmatic Environmental Assessment and Draft Finding of No Significant Impact Coast Guard, DHS. Notice of availability and request for comments. AGENCY: ACTION: The U.S. Coast Guard (USCG) announces the availability of the Draft Programmatic Environmental Assessment (PEA) for the Nationwide Use of High Frequency (HF) and Ultra High Frequency (UHF) Sound Navigation and Ranging (SONAR) Technology and Draft Finding of No Significant Impact (FONSI). The USCG is proposing the nationwide use of active SONAR technologies that operate at frequencies of 50 kiloHertz (kHz) and greater from mobile platforms. Active SONAR technology would be used in support of USCG missions to locate, image, and classify submerged/ underwater targets of interest (TOI). The PEA is a program-level document that will provide the USCG with management-level analysis of the potential impacts of each alternative on the human and natural environments. DATES: Comments and related material must either be submitted to our online docket via https://www.regulations.gov on or before January 31, 2011, or reach the Docket Management Facility by that date. ADDRESSES: The Draft PEA and Draft FONSI have been published and can be downloaded at https:// www.regulations.gov, docket number USCG–2009–0166. You may submit SUMMARY: E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 75, Number 247 (Monday, December 27, 2010)]
[Notices]
[Pages 81283-81284]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32464]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Child Health and Human Development Council.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Child Health and Human 
Development Council.
    Date: January 20, 2011.
    Open: 8 a.m. to 12:20 p.m.
    Agenda: (1) A report of the Director, NICHD; (2) Select Pay Plan 
Presentation; (3) NIH Peer Review Enhancement Update, (4) NIH 
Support for Human Embryonic Stem Cell Research Update.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
    Closed: 12:20 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National 
Institute of Child Health and Human Development, NIH, 9000 Rockville 
Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892. (301) 
496-1848.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: https://www.nichd.nih.gov/about/nachhd.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.
    In order to facilitate public attendance at the open session of 
Council, reserve seating will be made available to the first five 
individuals reserving seats in the main meeting room, Conference 
Room 6. Please contact Ms. Lisa Kaeser, Program and Public Liaison 
Office, NICHD, at 301-496-0536 to make your reservation. Additional 
seating will be available in the meeting overflow rooms, Conference 
Rooms 7 and 8. Individuals will also be able to view the meeting via 
NIH Videocast. Please go to the following link for Videocast access 
instructions at: https://wwwauthor.nichd.nih.gov/about/overview/advisory/nachhd/virtual-meeting-201005.cfm. The meeting is partially 
closed to the public.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)



[[Page 81284]]


    Dated: December 20, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-32464 Filed 12-23-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.